[Nucleoside analogues--new drugs for the treatment of lymphatic cancers].
Itälä
M
M
maija.itala@tyks.fi
Remes
K
K
D000903:Antibiotics, Antineoplastic / Q000493:pharmacokinetics / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017338:Cladribine / Q000493:pharmacokinetics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000378:metabolism; D008223:Lymphoma / Q000188:drug therapy* / Q000378:metabolism; D009705:Nucleosides / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015649:Pentostatin / Q000493:pharmacokinetics / Q000627:therapeutic use; D014740:Vidarabine / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D009705:Nucleosides; D015649:Pentostatin; D017338:Cladribine; D014740:Vidarabine; C024352:fludarabine